本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Atea Pharmaceuticals, Inc.

2.85
-0.1400-4.68%
盘后2.850.00000.00%16:10 EDT
成交量:34.80万
成交额:99.96万
市值:2.44亿
市盈率:-1.43
高:2.98
开:2.96
低:2.81
收:2.99
数据加载中...

公司资料

公司名字:
Atea Pharmaceuticals, Inc.
交易所:
NASDAQ
成立时间:
2012
员工人数:
56
公司地址:
225 Franklin Street,Suite 2100,Boston,Massachusetts,United States
邮编:
02110
电话:
传真:
- -
简介:
Atea Pharmaceuticals, Inc.于2012年7月注册成立,并于2014年3月开始主要运营。该公司是一家临床阶段的生物制药公司,利用对抗病毒药物开发、药物化学、生物学、生物化学和病毒学的深刻理解,发现和开发新型口服候选产品,以治疗严重的病毒性疾病。

董事

名称
职位
Jean Pierre Sommadossi
President and Chief Executive Officer and Chairman of the Board of Director
Andrew Hack
Director
Barbara Duncan
Director
Bruce Polsky
Director
Bruno Lucidi
Director
Franklin Berger
Director
Isaac Cheng
Director
Polly A. Murphy
Director

股东

名称
职位
Jean Pierre Sommadossi
President and Chief Executive Officer and Chairman of the Board of Director
Andrea Corcoran
Chief Financial Officer, Executive Vice President, Legal and Secretary
Wayne Foster
Senior Vice President, Finance and Administration
Janet Hammond
Chief Development Officer
John Vavricka
Chief Commercial Officer
Maria Arantxa Horga
Acting Chief Medical Officer